atrial fibrillation
Conditions
Interventions
Sponsors
Tianjin First Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18-75 years; 2. A clear diagnosis of patients with paroxysmal atrial fibrillation; 3. The subjects voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Cardiac function NYHA class III-IV, ventricular ejection fraction (LVEF) <= 40%; 2. With unsuccessful or recurrent radiofrequency ablation in the past; 3. Acute or severe systemic infection, significantly abnormal liver and kidney function, uncontrolled hyperthyroidism or malignant tumor and end-stage disease; 4. Preoperative determination of the presence of multiple types of tachyarrhythmias; 5. Combined with severe organic cardiovascular disease; 6. Stroke and other cerebrovascular diseases and thromboembolic diseases within the past 3 months; 7. Those who have obvious bleeding tendency or suffer from blood system diseases and cannot tolerate anticoagulant drugs; 8. Mental disorder or a history of mental illness and unable to cooperate voluntarily, patients with a history of epilepsy; 9. Pregnant and lactating patients and those planning to become pregnant within one year; 10. Those with allergies; 11. Those who have participated in clinical trials of any drug and/or medical device within 1 month before enrollment; 12. The researcher believes that there are any other factors that are not suitable for inclusion or that affect the participation of subjects in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate success rate;ECG; | — |
Countries
China
Contacts
Public ContactLu Chengzhi
Tianjin Medical University
Outcome results
None listed